-
1
-
-
15344341231
-
Thrombogenic and atherogenic activities of lysophosphatidic acid
-
Siess W., Tigyi G. Thrombogenic and atherogenic activities of lysophosphatidic acid. J Cell Biochem 2004, 92:1086-1094.
-
(2004)
J Cell Biochem
, vol.92
, pp. 1086-1094
-
-
Siess, W.1
Tigyi, G.2
-
2
-
-
33746617364
-
Platelet interaction with bioactive lipids formed by mild oxidation of low-density lipoprotein
-
Siess W. Platelet interaction with bioactive lipids formed by mild oxidation of low-density lipoprotein. Pathophysiol Haemost Thromb 2006, 35:292-304.
-
(2006)
Pathophysiol Haemost Thromb
, vol.35
, pp. 292-304
-
-
Siess, W.1
-
3
-
-
70349776386
-
Blood relatives: dynamic regulation of bioactive lysophosphatidic acid and sphingosine-1-phosphate metabolism in the circulation
-
Morris A.J., Selim S., Salous A., Smyth S.S. Blood relatives: dynamic regulation of bioactive lysophosphatidic acid and sphingosine-1-phosphate metabolism in the circulation. Trends Cardiovasc Med 2009, 19:135-140.
-
(2009)
Trends Cardiovasc Med
, vol.19
, pp. 135-140
-
-
Morris, A.J.1
Selim, S.2
Salous, A.3
Smyth, S.S.4
-
4
-
-
0037073806
-
Serum lysophosphatidic acid is produced through diverse phospholipase pathways
-
Aoki J., Taira A., Takanezawa Y., et al. Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 2002, 277:48737-48744.
-
(2002)
J Biol Chem
, vol.277
, pp. 48737-48744
-
-
Aoki, J.1
Taira, A.2
Takanezawa, Y.3
-
5
-
-
0033536049
-
Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions
-
Siess W., Zangl K.J., Essler M., et al. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci USA 1999, 96:6931-6936.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 6931-6936
-
-
Siess, W.1
Zangl, K.J.2
Essler, M.3
-
6
-
-
0043020630
-
Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques
-
Rother E., Brandl R., Baker D.L., et al. Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques. Circulation 2003, 108:741-747.
-
(2003)
Circulation
, vol.108
, pp. 741-747
-
-
Rother, E.1
Brandl, R.2
Baker, D.L.3
-
7
-
-
40749134619
-
Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway
-
Pamuklar Z., Lee J.S., Cheng H.Y., et al. Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway. Arterioscler Thromb Vasc Biol 2008, 28:555-561.
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, pp. 555-561
-
-
Pamuklar, Z.1
Lee, J.S.2
Cheng, H.Y.3
-
8
-
-
0036683314
-
Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids
-
Tokumura A., Sinomiya J., Kishimoto S., et al. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids. Biochem J 2002, 365:617-628.
-
(2002)
Biochem J
, vol.365
, pp. 617-628
-
-
Tokumura, A.1
Sinomiya, J.2
Kishimoto, S.3
-
9
-
-
79955032212
-
The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation
-
Bolen A.L., Naren A.P., Yarlagadda S., et al. The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation. J Lipid Res 2011, 52:958-970.
-
(2011)
J Lipid Res
, vol.52
, pp. 958-970
-
-
Bolen, A.L.1
Naren, A.P.2
Yarlagadda, S.3
-
10
-
-
0043165018
-
Plaque rupture, lysophosphatidic acid, and thrombosis
-
Spector A.A. Plaque rupture, lysophosphatidic acid, and thrombosis. Circulation 2003, 108:641-643.
-
(2003)
Circulation
, vol.108
, pp. 641-643
-
-
Spector, A.A.1
-
11
-
-
38049183243
-
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and
-
Antman E.M., Hand M., Armstrong P.W., et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008, 117:296-329.
-
(2008)
Circulation
, vol.117
, pp. 296-329
-
-
Antman, E.M.1
Hand, M.2
Armstrong, P.W.3
-
12
-
-
34548545280
-
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with th
-
Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007, 116:e148-e304.
-
(2007)
Circulation
, vol.116
-
-
Anderson, J.L.1
Adams, C.D.2
Antman, E.M.3
-
13
-
-
65549111017
-
Revised equations for estimated GFR from serum creatinine in Japan
-
Matsuo S., Imai E., Horio M., et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 53:982-992.
-
(2009)
Am J Kidney Dis
, vol.53
, pp. 982-992
-
-
Matsuo, S.1
Imai, E.2
Horio, M.3
-
14
-
-
0037505638
-
A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method
-
Kishimoto T., Matsuoka T., Imamura S., Mizuno K. A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method. Clin Chim Acta 2003, 333:59-67.
-
(2003)
Clin Chim Acta
, vol.333
, pp. 59-67
-
-
Kishimoto, T.1
Matsuoka, T.2
Imamura, S.3
Mizuno, K.4
-
15
-
-
34250686248
-
Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids
-
Nakamura K., Kishimoto T., Ohkawa R., et al. Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids. Anal Biochem 2007, 367:20-27.
-
(2007)
Anal Biochem
, vol.367
, pp. 20-27
-
-
Nakamura, K.1
Kishimoto, T.2
Ohkawa, R.3
-
16
-
-
0036629774
-
An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma
-
Kishimoto T., Soda Y., Matsuyama Y., Mizuno K. An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma. Clin Biochem 2002, 35:411-416.
-
(2002)
Clin Biochem
, vol.35
, pp. 411-416
-
-
Kishimoto, T.1
Soda, Y.2
Matsuyama, Y.3
Mizuno, K.4
-
17
-
-
0034010934
-
Spectrophotometric assay for serum platelet-activating factor acetylhydrolase activity
-
Kosaka T., Yamaguchi M., Soda Y., et al. Spectrophotometric assay for serum platelet-activating factor acetylhydrolase activity. Clin Chim Acta 2000, 296:151-161.
-
(2000)
Clin Chim Acta
, vol.296
, pp. 151-161
-
-
Kosaka, T.1
Yamaguchi, M.2
Soda, Y.3
-
18
-
-
37249005340
-
Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation
-
Nakamura K., Igarashi K., Ide K., et al. Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. Clin Chim Acta 2008, 388:51-58.
-
(2008)
Clin Chim Acta
, vol.388
, pp. 51-58
-
-
Nakamura, K.1
Igarashi, K.2
Ide, K.3
-
19
-
-
0037162054
-
Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate
-
Siess W. Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. Biochim Biophys Acta 2002, 1582:204-215.
-
(2002)
Biochim Biophys Acta
, vol.1582
, pp. 204-215
-
-
Siess, W.1
-
20
-
-
77953186516
-
Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation
-
Bot M., Bot I., Lopez-Vales R., et al. Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation. Am J Pathol 2010, 176:3073-3084.
-
(2010)
Am J Pathol
, vol.176
, pp. 3073-3084
-
-
Bot, M.1
Bot, I.2
Lopez-Vales, R.3
-
21
-
-
49949110717
-
Roles of lysophosphatidic acid in cardiovascular physiology and disease
-
Smyth S.S., Cheng H.Y., Miriyala S., Panchatcharam M., Morris A.J. Roles of lysophosphatidic acid in cardiovascular physiology and disease. Biochim Biophys Acta 2008, 1781:563-570.
-
(2008)
Biochim Biophys Acta
, vol.1781
, pp. 563-570
-
-
Smyth, S.S.1
Cheng, H.Y.2
Miriyala, S.3
Panchatcharam, M.4
Morris, A.J.5
-
22
-
-
80052472799
-
The role of PGE(2) in human atherosclerotic plaque on platelet EP(3) and EP (4) receptor activation and platelet function in whole blood
-
Schober L.J., Khandoga A.L., Dwivedi S., et al. The role of PGE(2) in human atherosclerotic plaque on platelet EP(3) and EP (4) receptor activation and platelet function in whole blood. J Thromb Thrombolysis 2011, 32:158-166.
-
(2011)
J Thromb Thrombolysis
, vol.32
, pp. 158-166
-
-
Schober, L.J.1
Khandoga, A.L.2
Dwivedi, S.3
-
23
-
-
1642512389
-
Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction
-
Chen X., Yang X.Y., Wang N.D., et al. Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction. Scand J Clin Lab Invest 2003, 63:497-503.
-
(2003)
Scand J Clin Lab Invest
, vol.63
, pp. 497-503
-
-
Chen, X.1
Yang, X.Y.2
Wang, N.D.3
-
24
-
-
47749147683
-
Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity
-
Hosogaya S., Yatomi Y., Nakamura K., et al. Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity. Ann Clin Biochem 2008, 45:364-368.
-
(2008)
Ann Clin Biochem
, vol.45
, pp. 364-368
-
-
Hosogaya, S.1
Yatomi, Y.2
Nakamura, K.3
-
25
-
-
46749147203
-
Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases
-
Gendaszewska-Darmach E. Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases. Acta Biochim Pol 2008, 55:227-240.
-
(2008)
Acta Biochim Pol
, vol.55
, pp. 227-240
-
-
Gendaszewska-Darmach, E.1
-
26
-
-
0037197780
-
Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies
-
Burke A.P., Tracy R.P., Kolodgie F., et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002, 105:2019-2023.
-
(2002)
Circulation
, vol.105
, pp. 2019-2023
-
-
Burke, A.P.1
Tracy, R.P.2
Kolodgie, F.3
-
27
-
-
0343852114
-
Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions
-
Hakkinen T., Luoma J.S., Hiltunen M.O., et al. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1999, 19:2909-2917.
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, pp. 2909-2917
-
-
Hakkinen, T.1
Luoma, J.S.2
Hiltunen, M.O.3
-
28
-
-
33644830673
-
Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans
-
Yang E.H., McConnell J.P., Lennon R.J., et al. Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol 2006, 26:106-111.
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 106-111
-
-
Yang, E.H.1
McConnell, J.P.2
Lennon, R.J.3
-
29
-
-
30944447092
-
Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis
-
Kougias P., Chai H., Lin P.H., Lumsden A.B., Yao Q., Chen C. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit 2006, 12:RA5-RA16.
-
(2006)
Med Sci Monit
, vol.12
-
-
Kougias, P.1
Chai, H.2
Lin, P.H.3
Lumsden, A.B.4
Yao, Q.5
Chen, C.6
-
30
-
-
0036119155
-
Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism
-
Takahashi M., Okazaki H., Ogata Y., Takeuchi K., Ikeda U., Shimada K. Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism. Atherosclerosis 2002, 161:387-394.
-
(2002)
Atherosclerosis
, vol.161
, pp. 387-394
-
-
Takahashi, M.1
Okazaki, H.2
Ogata, Y.3
Takeuchi, K.4
Ikeda, U.5
Shimada, K.6
-
31
-
-
0033867025
-
Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL
-
Hsieh C.C., Yen M.H., Liu H.W., Lau Y.T. Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL. Atherosclerosis 2000, 151:481-491.
-
(2000)
Atherosclerosis
, vol.151
, pp. 481-491
-
-
Hsieh, C.C.1
Yen, M.H.2
Liu, H.W.3
Lau, Y.T.4
-
32
-
-
34249701265
-
Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans
-
Lavi S., McConnell J.P., Rihal C.S., et al. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans. Circulation 2007, 115:2715-2721.
-
(2007)
Circulation
, vol.115
, pp. 2715-2721
-
-
Lavi, S.1
McConnell, J.P.2
Rihal, C.S.3
-
33
-
-
14144256273
-
Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up
-
Brilakis E.S., McConnell J.P., Lennon R.J., Elesber A.A., Meyer J.G., Berger P.B. Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up. Eur Heart J 2005, 26:137-144.
-
(2005)
Eur Heart J
, vol.26
, pp. 137-144
-
-
Brilakis, E.S.1
McConnell, J.P.2
Lennon, R.J.3
Elesber, A.A.4
Meyer, J.G.5
Berger, P.B.6
-
34
-
-
79955596968
-
Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium
-
Zhou Z., Subramanian P., Sevilmis G., et al. Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium. Cell Metab 2011, 13:592-600.
-
(2011)
Cell Metab
, vol.13
, pp. 592-600
-
-
Zhou, Z.1
Subramanian, P.2
Sevilmis, G.3
|